Abiopharma

Cipher Pharmaceuticals Inc. ("Cipher") is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. Cipher operates a lean corporate structure, employs strategic operational partnerships, out and in-licenses products, in addition to making selective investments in drug development to assemble a broad portfolio of prescription products.

Additional info from OTC:
Cipher Pharmaceuticals Inc. ("Cipher") is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. Cipher operates a lean corporate structure, employs strategic operational partnerships, out and in-licenses products, in addition to making selective investments in drug development to assemble a broad portfolio of prescription products.